您的位置: 中国博士人才网 > 博士后招收 > 海外博士后招收 > 美国德克萨斯大学安德森癌症中心招收博后

美国德克萨斯大学安德森癌症中心招收博后

时间:2016-07-20来源:未知 作者:91boshi

Lymphoma/Myeloma Postdoctoral Fellow : Houston, TX, United States

The University of Texas MD Anderson Cancer Center invites applications for a postdoctoral fellowship available in Dr. Michael Wang’s lab at MD Anderson Cancer Center. This is a full-time, hands-on laboratory post-doctoral research position in the Department of Lymphoma/Myeloma. Applicants must have a recent Ph.D. and/or M.D. with focused research on the relevant subjects. The successful candidate will have a track record of productivity in research and have the talent and dedication to take advantage of the vast resources available at The University of Texas MD Anderson Cancer Center.

We are looking for highly motivated and interactive colleagues, who are interested in applying his/her knowledge in in vivo tumor models, functional genomics, cancer biology, cell signaling, molecular biology, and pharmacology and to solve some therapeutic challenges in lymphoma, are highly encouraged to apply. Experience in one of the following areas is preferred: animal models, cancer biology, experimental therapeutics, pharmacology, and metabolisms, or molecular biology.

The University of Texas MD Anderson is centered in the vibrant research environment of the Houston Texas Medical Center, which includes Baylor College of Medicine, The University of Texas Medical School, the Methodist Hospital Research Institute, and Rice University, and ranks 1st in the number of awarded grants from National Cancer Institute. It offers active graduate and postdoctoral training programs and the unmatched scientific environment of the Texas Medical Center, the world’s largest biomedical center.

中国-博士人才网发布

声明:凡本网注明“来源:XXX”的文/图等稿件,本网转载出于传递更多信息及方便产业探讨之目的,并不意味着本站赞同其观点或证实其内容的真实性,文章内容仅供参考。

------分隔线----------------------------
博士交流群:更多>>
【01号群】52394121;【02号群】29897443;【03号群】120320822
【04号群】71153177;【05号群】75698417;【06号群】177347342
【07号群】126881746;【08号群】145243525;【09号群】202869152
隐藏
展开